Potential Drug-Related Problems in Pediatric Patients-Describing the Use of a Clinical Decision Support System at Pharmacies in Sweden.

EES alerts clinical decision support system dispensing drug-related problems pediatric pharmacy

Journal

Pharmacy (Basel, Switzerland)
ISSN: 2226-4787
Titre abrégé: Pharmacy (Basel)
Pays: Switzerland
ID NLM: 101678532

Informations de publication

Date de publication:
14 Feb 2023
Historique:
received: 03 11 2022
revised: 16 01 2023
accepted: 08 02 2023
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 25 2 2023
Statut: epublish

Résumé

The clinical support system Electronic Expert Support (EES) is available at all pharmacies in Sweden to examine electronic prescriptions when dispensing to prevent drug-related problems (DRPs). DRPs are common, and result in patient suffering and substantial costs for society. The aim of this research was to study the use of EES for the pediatric population (ages 0-12 years), by describing what types of alerts are generated for potential DRPs, how they are handled, and how the use of EES has changed over time. Data on the number and categories of EES analyses, alerts, and resolved alerts were provided by the Swedish eHealth Agency. The study shows that the use of EES has increased. The most common type of alert for a potential DRP among pediatric patients was regarding high doses in children (30.3% of all alerts generated). The most common type of alert for a potential DRP that was resolved among pediatrics was therapy duplication (4.6% of the alerts were resolved). The most common reason for closing an alert was dialogue with patient for verification of the treatment (66.3% of all closed alerts). Knowledge of which type of alerts are the most common may contribute to increased prescriber awareness of important potential DRPs.

Identifiants

pubmed: 36827673
pii: pharmacy11010035
doi: 10.3390/pharmacy11010035
pmc: PMC9967379
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Clin Pharm Ther. 2022 Mar;47(3):330-344
pubmed: 34734650
Int J Clin Pharm. 2014 Oct;36(5):943-52
pubmed: 24974220
BMC Med Inform Decis Mak. 2013 Oct 01;13:111
pubmed: 24083548
Appl Clin Inform. 2014 Sep 03;5(3):802-13
pubmed: 25298818
Int J Clin Pharm. 2023 Feb;45(1):88-96
pubmed: 36307661
PLoS One. 2022 Jun 3;17(6):e0269322
pubmed: 35657965
JAMA. 2001 Apr 25;285(16):2114-20
pubmed: 11311101
Acta Paediatr. 2012 Jul;101(7):772-8
pubmed: 22404126
Acta Paediatr. 2011 Sep;100(9):1272-5
pubmed: 21438922
BMC Pediatr. 2019 Aug 13;19(1):281
pubmed: 31409339
J Pediatr Pharmacol Ther. 2019 Jul-Aug;24(4):304-311
pubmed: 31337993
Pediatrics. 2014 Aug;134(2):361-72
pubmed: 25022739
Br J Clin Pharmacol. 2022 May;88(5):2035-2051
pubmed: 34837238
Pharmacoepidemiol Drug Saf. 2016 Jan;25(1):82-9
pubmed: 26602064
Am J Health Syst Pharm. 2018 Feb 15;75(4):239-246
pubmed: 29436470
Int J Clin Pharm. 2015 Oct;37(5):941-8
pubmed: 26047943
Healthcare (Basel). 2021 Mar 14;9(3):
pubmed: 33799438
PLoS One. 2019 Aug 5;14(8):e0220685
pubmed: 31381591
Pharmacy (Basel). 2020 Jul 13;8(3):
pubmed: 32668586
JMIR Med Inform. 2020 Jul 22;8(7):e18758
pubmed: 32706717
Pediatrics. 2009 Apr;123(4):1184-90
pubmed: 19336379
Eur J Clin Pharmacol. 2014 Nov;70(11):1375-83
pubmed: 25190295
Pharmacy (Basel). 2022 Dec 30;11(1):
pubmed: 36649016
Eur J Clin Pharmacol. 2009 Jun;65(6):627-33
pubmed: 19205683
Stud Health Technol Inform. 2022 Jun 6;290:380-384
pubmed: 35673040
BMJ Open. 2019 Aug 10;9(8):e028680
pubmed: 31401597

Auteurs

Sazan Abass Abdulkadir (SA)

Department of Pharmacy, Faculty of Pharmacy, Uppsala University, 752 37 Uppsala, Sweden.

Björn Wettermark (B)

Department of Pharmacy, Faculty of Pharmacy, Uppsala University, 752 37 Uppsala, Sweden.

Tora Hammar (T)

The eHealth Institute, Department of Medicine and Optometry, Linnaeus University, 391 82 Kalmar, Sweden.

Classifications MeSH